For years, patients have been misled by “bad drug” ads that frighten them into abandoning their prescription medications. Now the Federal Trade Commission is speaking out.
For the first time, the commission has warned the law firms and aggregators sponsoring such ads that their practices may be “deceptive” and “unfair.”